Has low-dose intracoronary thrombolysis gained ground in primary percutaneous intervention?
Kaddoura R, Mohamed Ibrahim MI, Arabi AR.
Angiology. 2022 Nov 4:33197221138725. doi: 10.1177/00033197221138725. Online ahead of print.
PMID:36331138
Safety and efficacy of low-dose intracoronary thrombolysis during primary percutaneous coronary intervention in patients with ST elevation myocardial infarction: A meta-analysis of randomized trials.
Management of no Reflow during Percutaneous Transcoronary Angioplasty with Catheter-Directed Intracoronary Thrombolysis: A Retrospective Observational Study.
Singh R, Singla SK, Singla A, Manchanda S, Kaur M.
Int J Appl Basic Med Res. 2022 Oct-Dec;12(4):260-264. doi: 10.4103/ijabmr.ijabmr_407_22. Epub 2022 Dec 19.
PMID:36726658
Novel Therapeutic Strategies to Reduce Reperfusion Injury After Acute Myocardial Infarction.
Intracoronary thrombolysis and stentless primary percutaneous coronary intervention in an ectatic right coronary artery with large thrombus burden.
Kassimis G, Faliagkas P, Pshochias P, Karagiannidis E, Peteinidou E, Chatzinikolaou E, Ziakas A, Sianos G.
Future Cardiol. 2021 Sep;17(6):999-1006. doi: 10.2217/fca-2020-0141. Epub 2020 Dec 10.
PMID:33300808
Intracoronary artery retrograde thrombolysis combined with percutaneous coronary interventions for ST-segment elevation myocardial infarction complicated with diabetes mellitus: A case report and literature review.
Shen M, Liao Y, Wang J, Zhou X, Guo Y, Nong Y, Guo Y, Lu H, Jin R, Wang J, Fu Z, Li D, Zhao S, Tian J.
Front Cardiovasc Med. 2022 Jul 22;9:962127. doi: 10.3389/fcvm.2022.962127. eCollection 2022.
PMID:35935661
Intracoronary arterial retrograde thrombolysis with percutaneous coronary intervention: a novel use of thrombolytic to treat acute ST-segment elevation myocardial infarction.
Tian JW, Zhu M, Wang FQ, Li K, Zhou CF, Li B, Wang M, Deng JL, Jiang B, Bai J, Guo Y, Jin RJ, Zhang Z, Lin Y, Wang JH, Zhao SH, Shen MZ.
Long-term outcome of patients with ST-segment elevation myocardial infarction treated with low-dose intracoronary thrombolysis during primary percutaneous coronary intervention: the 5-year results of the DISSOLUTION Trial.
Pelliccia F, Greco C, Tanzilli G, Viceconte N, Schiariti M, Gaudio C.